Scarica l'app Stockscreener
37.50
0.03%
0.03
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why - TradingView
Collegium (NASDAQ: COLL) details $655.6M AZSTARYS acquisition terms - Stock Titan
Collegium Pharmaceutical, Inc. Actuals & Estimates (NASDAQ:COLL) - TradingView
COLL Forecast — Price Target — Prediction for 2027 - TradingView
How (COLL) Movements Inform Risk Allocation Models - Stock Traders Daily
Collegium Pharmaceutical Inc (COLL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Collegium Pharmaceutical stock rises toward upper weekly range amid short-term recovery - Traders Union
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) Institutional Confidence - TradingKey
Did Collegium Pharmaceutical’s Profitability Surge and Efficiency Gains Just Shift COLL’s Investment Narrative? - simplywall.st
Collegium Pharmaceutical Inc (COLL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Collegium Pharmaceutical Inc (COLL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Collegium Pharmaceutical Inc (COLL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Collegium Pharmaceutical Inc (COLL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
COLL Stock Price, Quote & Chart - ChartMill
Collegium Pharmaceutical Inc - TradingKey
Collegium Pharmaceutical Inc (COLL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Collegium Pharmaceutical Inc (COLL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Trading Systems Reacting to (COLL) Volatility - Stock Traders Daily
Collegium Pharmaceutical Inc. Q1 2026 Earnings: EPS Surges Past Estimates on Strong Operational Execution - newsline.com
COLLEGIUM PHARMACEUTICAL (COLL) director exercises options, now holds 112,483 shares - Stock Titan
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director SANTINI GINO - Moomoo
Collegium Pharmaceutical stock gains stall near resistance despite 4.17 percent weekly rise - Traders Union
Collegium Pharmaceutical grants 50,305 RSUs to 34 new hires as inducement under Nasdaq rules. - Pluang
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
2 Reasons to Sell COLL and 1 Stock to Buy Instead - Yahoo Finance
Assessing Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Weakness - Yahoo Finance
Collegium Pharmaceutical | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Collegium Pharmaceutical Gains Attention on Strong ADHD Portfolio and Q1 2026 BeatEPS Revision Trend - thelegaladvocate.com
This Insider Has Just Sold Shares In Collegium Pharmaceutical - 富途牛牛
Why Collegium Pharmaceutical Inc. (COLL) Stock Is Gaining Attention for Its ADHD Portfolio - Insider Monkey
Collegium to Participate in 2026 Jefferies Global Healthcare Conference - The Manila Times
Investors can stream Collegium's Jefferies healthcare fireside chat live - Stock Titan
Collegium Pharmaceutical Acquires ADHD Drug AZSTARYS® from Corium Therapeutics - geneonline.com
COLLCollegium Pharmaceutical Inc Stock Price and Quote - Finviz
Collegium Pharmaceutical (COLL) Holds Near Resistance After Slight DeclineOvernight Profile - dars.gov.et
Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q1 - TradingView
(COLL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
How Strong Q1 Earnings and Executive Departures At Collegium Pharmaceutical (COLL) Have Changed Its Investment Story - simplywall.st
Collegium Pharmaceutical stock (US19459E1029): insider trade draws attention as Wall Street sees ups - AD HOC NEWS
Collegium (NASDAQ: COLL) director sells 20 shares, holds 83,952 - Stock Titan
Collegium Pharma Leans on ADHD to Drive Growth - TipRanks
Collegium pharmaceutical director sells $142k in shares By Investing.com - Investing.com Australia
Collegium pharmaceutical director sells $142k in shares - Investing.com India
Director Nancy Lurker awarded 8,741 RSUs at Collegium (COLL) - Stock Titan
Director Carlos V. Paya granted 8,741 RSUs at COLLEGIUM (NASDAQ: COLL) - Stock Titan
Collegium (COLL) director sells shares, exercises options and receives RSU grant - Stock Titan
Director at Collegium (COLL) awarded 17,482 restricted stock units - Stock Titan
Director at Collegium (NASDAQ: COLL) receives 8,741 RSUs in equity award - Stock Titan
Director at Collegium (NASDAQ: COLL) awarded 8,741 RSUs in equity grant - Stock Titan
COLL (NASDAQ) Form 144 shows 4,127-share sale and 30-share resale notice - Stock Titan
Collegium Pharmaceutical (COLL) director Donovan Glancy files initial Form 3 - Stock Titan
Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Paya Carlos V - Moomoo
Have Collegium Pharmaceutical Insiders Been Selling Stock? - simplywall.st
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know - Yahoo Finance
0.67%
1.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):